Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arthronica is a UK digital health company focused on remote monitoring and rehabilitation for arthritis and other chronic rheumatic conditions. Its platform uses computer vision and artificial intelligence to analyze patient-recorded videos, questionnaires, and related clinical data to quantify joint range of motion and track disease activity outside the clinic. The company originated as an Imperial College London spin-out in 2018 and was acquired by Procedure Health Limited in 2022, where Arthronica appears to continue as an operating product/platform. Arthronica has been used in clinical-trial and care settings in the United Kingdom and United States, with an initial emphasis on rheumatoid arthritis. The business is best characterized as a healthtech/software company rather than a therapeutics developer, with no conventional drug pipeline disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arthronica.